Given that PTEN deletion has been associated with increased genomic instability in prostate cancer (49), this finding raises the question of whether PGA might be lower among prostate tumors from BL compared with WH men, and if not, whether there are other genomic alterations driving adverse outcomes that may be more common among BL men. The gene discussed is PTEN; the disease is prostate cancer.